What is ACHIEVE?

Cervical cancer is a 100% preventable cancer, given effective HPV vaccination and early detection strategies. Yet, over 4,000 women die each year in the United States, particularly women from marginalized groups such as American Indian/Alaska Native, Hispanic/Latinx and non-Hispanic Black women. Compared to non-Hispanic White women, American Indian/Alaska Native and Hispanic/Latinx women had the highest incidence rates of cervical cancer in 2025, while American Indian/Alaska Native and non-Hispanic Black women had the highest mortality rates. These disparities are due to the impacts of structural racism across the care continuum.  

 

Thus, The ACHIEVE (Assessing Cervical Cancer Healthcare Inequities in Diverse Populations) Study will investigate the contribution of structural racism to inequities in cervical cancer treatment and survival. 

 

This project is a collaboration between The Columbia University Mailman School of Public Health (MSPH), The University of Southern California (USC) Keck School of Medicine, the Los Angeles County Cancer Surveillance Program (LACSP), and the New Jersey State Cancer Registry (NJSCR) managed by the Rutgers Cancer Institute (RCI).

​

​

The NJSCR is funded by the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) Program (#75N91021D00009), Centers for Disease Control and Prevention’s National Program of Cancer Registries (#NU58DP007117) with additional support from the State of New Jersey and the Rutgers Cancer Institute.  The LACSP is supported by the National Cancer Institute's Surveillance, Epidemiology and End Results Program (HHSN261201800015I) and the Centers for Disease Control and Prevention's (CDC) National Program of Cancer Registries (5NU58DP006344).